Alamar Biosciences is a proteomics company that develops NULISA, a platform technology for detecting and measuring protein biomarkers in blood samples for disease diagnosis and research. The company manufactures the ARGO system, an automated instrument for high-sensitivity protein analysis, along with related supplies and analytical services used across immunology, neurology, and oncology research. The firm serves pharmaceutical companies, research institutions, and contract labs worldwide, and maintains a partnership focused on advancing Alzheimer's disease research.
1Y: 30.60 (+39.1%) · range 19.09–38.13
entry readiness 9 · NOT READY · exit proximity 0
Value area 23.42–33.80 · 38% of 120d volume overhead · moderate overhead
No source detections in the last 21 days.
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | -20.81% | -2.82% | mature |
| 40d | -24.06% | +4.27% | mature |